
Balchem (BCPC) Earnings
Price: $165.20
Market Cap: $5.37B
Market Cap: $5.37B
Revenue (TTM): $953.68M
Net Income: $128.47M
Net Income: $128.47M
P/E Ratio: 41.85
EPS (TTM): $3.95
EPS (TTM): $3.95
Earnings Dates
Balchem (BCPC) reports its earnings quarterly. Here are the key details:
Next Earnings Date
- Date: May 02, 2025
- Time of Day: Before Market Open
- Estimated EPS: $1.12
Last Earnings Report
- Date: February 21, 2025
- EPS: $1.03
- EPS Estimate: $1.11
Balchem's next earnings report is scheduled for May 02, 2025.
In its last earnings report on February 21, 2025, Balchem reported earnings per share (EPS) of $1.03, compared to an estimated EPS of $1.11. The company reported revenue of $240.00M, compared to an estimated revenue of $244.91M.
Earnings Call Transcripts
Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
---|---|---|---|---|---|
Read Transcript | Q4 | 2024 | 2025-02-21 | $1.11 | $1.03 |
Read Transcript | Q3 | 2024 | 2024-10-25 | $1.11 | $1.13 |
Read Transcript | Q2 | 2024 | 2024-07-26 | $1.03 | $1.09 |
Read Transcript | Q1 | 2024 | 2024-05-03 | $0.98 | $1.03 |
Read Transcript | Q4 | 2023 | 2024-02-16 | $0.93 | $0.95 |
Read Transcript | Q3 | 2023 | 2023-10-27 | $0.97 | $1.04 |
Read Transcript | Q2 | 2023 | 2023-07-28 | $0.84 | $1.06 |
Read Transcript | Q1 | 2023 | 2023-04-28 | $0.78 | $0.70 |
Read Transcript | Q4 | 2022 | 2023-02-24 | $0.90 | $0.66 |
Read Transcript | Q3 | 2022 | 2022-11-04 | $0.85 | $1.00 |
Read Transcript | Q2 | 2022 | 2022-07-29 | $0.91 | $1.07 |
Read Transcript | Q1 | 2022 | 2022-04-29 | $0.79 | $1.03 |
Read Transcript | Q4 | 2021 | 2022-02-18 | $0.85 | $0.85 |
Read Transcript | Q3 | 2021 | 2021-10-29 | $0.90 | $0.92 |
Read Transcript | Q2 | 2021 | 2021-08-01 | N/A | N/A |
Read Transcript | Q1 | 2021 | 2021-05-02 | N/A | N/A |
Read Transcript | Q4 | 2020 | 2021-02-19 | $0.81 | $0.83 |
Read Transcript | Q3 | 2020 | 2020-10-28 | $0.70 | $0.83 |
Read Transcript | Q2 | 2020 | 2020-07-31 | $0.56 | $0.85 |
Read Transcript | Q1 | 2020 | 2020-05-01 | $0.59 | $0.81 |
Read Transcript | Q4 | 2019 | 2020-02-21 | $0.84 | $0.88 |
Read Transcript | Q3 | 2019 | 2019-11-05 | $0.74 | $0.81 |
Read Transcript | Q2 | 2019 | 2019-08-04 | N/A | N/A |
Read Transcript | Q1 | 2019 | 2019-05-04 | N/A | N/A |
Read Transcript | Q4 | 2018 | 2019-03-03 | N/A | N/A |
Read Transcript | Q3 | 2018 | 2018-11-10 | N/A | N/A |
Read Transcript | Q2 | 2018 | 2018-08-03 | $0.76 | $0.76 |
Read Transcript | Q1 | 2018 | 2018-05-04 | $0.71 | $0.76 |
Read Transcript | Q4 | 2017 | 2018-02-28 | N/A | N/A |
Read Transcript | Q3 | 2017 | 2017-11-11 | N/A | N/A |
Read Transcript | Q2 | 2017 | 2017-08-04 | $0.63 | $0.64 |
Read Transcript | Q1 | 2017 | 2017-05-12 | N/A | N/A |
Read Transcript | Q4 | 2016 | 2017-02-28 | $0.65 | $0.67 |
Read Transcript | Q3 | 2016 | 2016-11-04 | $0.65 | $0.61 |
Read Transcript | Q2 | 2016 | 2016-08-05 | $0.65 | $0.66 |
Read Transcript | Q1 | 2016 | 2016-05-10 | $0.62 | $0.58 |
Earnings History
Date | EPS | EPS Estimate | Revenue | Revenue Estimate |
---|---|---|---|---|
February 21, 2025 | $1.03 | $1.11 | $240.00M | $244.91M |
October 25, 2024 | $1.13 | $1.11 | $239.94M | $235.08M |
July 26, 2024 | $1.09 | $1.03 | $234.08M | $239.69M |
May 03, 2024 | $1.03 | $0.98 | $239.66M | $232.46M |
February 16, 2024 | $0.95 | $0.93 | $228.70M | $234.66M |
October 27, 2023 | $1.04 | $0.97 | $229.95M | $237.08M |
July 28, 2023 | $1.06 | $0.84 | $231.25M | $243.98M |
April 28, 2023 | $0.70 | $0.78 | $232.54M | $231.83M |
February 24, 2023 | $0.66 | $0.90 | $232.53M | $241.47M |
November 04, 2022 | $1.00 | $0.85 | $244.27M | $239.62M |
July 29, 2022 | $1.07 | $0.91 | $236.69M | $223.53M |
April 29, 2022 | $1.03 | $0.79 | $228.87M | $207.69M |
February 18, 2022 | $0.85 | $0.85 | $213.13M | $198.17M |
October 29, 2021 | $0.92 | $0.90 | $197.87M | $196.85M |
July 30, 2021 | $0.93 | $0.88 | $202.37M | $202.37M |
April 30, 2021 | $0.87 | $0.85 | $185.66M | $181.41M |
February 19, 2021 | $0.83 | $0.81 | $180.71M | $175.33M |
Annual Earnings
Annual Revenue
$953.68M
Fiscal Year 2024Annual Net Income
$128.47M
Fiscal Year 2024Annual EPS
$3.97
Fiscal Year 2024Quarterly Earnings
Revenue
$240.00M
Quarter Ending December 31, 2024Net Income
$33.58M
Quarter Ending December 31, 2024EPS
$1.03
Quarter Ending December 31, 2024Earnings Metrics
Earnings Yield
2.44%
Year Ending December 31, 2024P/E Ratio
41.02
Year Ending December 31, 2024Revenue Per Share
$29.50
Year Ending December 31, 2024Earnings Yield (TTM)
2.39%
Trailing Twelve MonthsP/E Ratio (TTM)
41.85
Trailing Twelve MonthsRevenue Per Share (TTM)
$29.30
Trailing Twelve MonthsFrequently Asked Questions
Balchem's next earnings date is scheduled for May 02, 2025. The earnings call is expected to take place before market open.
In its last earnings report on February 21, 2025, Balchem reported earnings per share (EPS) of $1.03, compared to an estimated EPS of $1.11. The company reported revenue of $240.00M, compared to an estimated revenue of $244.91M.
Balchem's current Price-to-Earnings (P/E) ratio is 41.02. The trailing twelve months (TTM) P/E ratio is 41.85. The P/E ratio is a valuation metric that compares a company's current share price to its earnings per share (EPS). A higher P/E ratio suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E ratio.
For the fiscal year ending December 31, 2024, Balchem reported total revenue of $953.68M and net income of $128.47M. This represents a net profit margin of 0.1347144337.
Balchem's earnings yield is 2.44%. The earnings yield is the inverse of the P/E ratio and represents the percentage of each dollar invested in the stock that was earned by the company.
Balchem's return on equity (ROE) is 11.17%. ROE is a measure of financial performance calculated by dividing net income by shareholders' equity. It measures how effectively management is using a company's assets to create profits.
Balchem's gross profit margin is 35.25%. This indicates that for every dollar of revenue, the company retains $0.35 as gross profit after accounting for the cost of goods sold.
Related Metrics
Explore detailed financial metrics and analysis for BCPC.